ANIX

SEC Filing Summary: CopyTele, Inc. (10-Q)

Business Context and Reporting Period

Company: CopyTele, Inc. (Note: Input metadata referenced Anixa Biosciences, but the filing text is for CopyTele, Inc.)
Reporting Period: Quarter ended January 31, 2000.
Status: Development Stage Enterprise.
Operations: The company develops, produces, and markets multi-functional encryption and telecommunications products, specifically the USS-900 (digital encryption system) and the SCS-700 (secure communication system). It maintains a 55% owned joint venture in Shanghai, China (Shanghai CopyTele) for manufacturing components.

Key Financial Metrics

Debt & Liquidity: The company has no long-term debt listed on the balance sheet. Liquidity is maintained through cash reserves and proceeds from stock sales and option exercises. The company owes approximately $862,000 to its Joint Venture, which is netted against receivables in the financial statements.

Material Changes vs. Prior Period

• Revenue Generation: The company recorded $276,792 in sales for the quarter ended January 31, 2000, compared to zero sales in the same period in 1999.
• Expense Management: Selling, General, and Administrative (SG&A) expenses remained relatively flat, increasing slightly from $1,415,282 to $1,422,369. This stability was achieved despite increased marketing costs and professional fees, offset by reductions in employee compensation and R&D costs.
• Joint Venture Accounting: The company discontinued recording its share of the Shanghai CopyTele Joint Venture's losses as of October 31, 1999, following a permanent impairment charge. Consequently, no loss from the Joint Venture was recorded in Q1 2000, compared to a $68,628 loss in Q1 1999.
• Inventory: Inventory decreased slightly from $4,538,608 to $4,356,490.

Outlook, Risks, and Management Commentary

• Liquidity Outlook: Management believes current cash resources, combined with proceeds received in February and March 2000, are sufficient to fund operations through the first quarter of fiscal 2001. Additional financing will likely be required thereafter.
• Financing Needs: The company may need to raise additional equity to maintain its NASD listing, which requires a minimum of $4 million in net tangible assets (currently ~$6.09 million) and a minimum bid price of $1.00 per share.
• Key Risks:
  • Development Stage: The company has incurred net losses since inception (1982) and has limited sales history.
  • Product Viability: Success depends on marketing the USS-900 and SCS-700, securing encryption chips from Harris Corporation, and managing supply chains.
  • Joint Venture Uncertainty: Realizability of the investment in Shanghai CopyTele is uncertain; the company has reserved ~$1.4 million against amounts due from the venture.
  • Inventory Valuation: Inventory is carried at estimated net realizable value; further price reductions may be necessary to sell stock.
• Unusual Items: Significant salary and pension benefit waivers by the Chairman, President, and senior personnel continue to reduce operating costs.

Investor Verification Checklist

• Revenue Sustainability: Verify if the $277k in sales represents a recurring trend or a one-time event, given the company's history of zero sales.
• Joint Venture Exposure: Confirm the status of the $862,000 receivable from Shanghai CopyTele and the likelihood of recovery given the venture's cumulative losses.
• Inventory Realizability: Assess the risk of further inventory write-downs given the limited sales volume and the company's reliance on estimated net realizable value.
• Capital Requirements: Evaluate the timeline for the next round of financing needed to sustain operations beyond Q1 fiscal 2001 and the potential dilution to shareholders.
• NASD Compliance: Monitor the stock price to ensure it remains above the $1.00 minimum bid price required for NASD listing.